XML 18 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 3 - Fair Value of Financial Instruments (Details) - Summary of changes in the fair value of the Company’s Level 3 fair value measurements: (USD $)
6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Accrued Warrant Liability [Member] | Three Months [Member]
   
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Beginning balance $ 7,553,382 $ 5,566,203
Total (gains) or losses, realized and unrealized, included in earnings (1)(2) (2,795,612) [1] (2,543,270) [1]
Estimates and other changes in fair value    [2]    [2]
Balance, 4,757,770 3,022,933
Accrued Warrant Liability [Member] | Six Months [Member]
   
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Beginning balance 4,105,659 7,285,959
Total (gains) or losses, realized and unrealized, included in earnings (1)(2) 652,111 [1] (4,263,026) [1]
Estimates and other changes in fair value    [2]    [2]
Balance, 4,757,770 3,022,933
Compensatory Stock Options Not Yet Issued [Member] | Three Months [Member]
   
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Beginning balance 63,641 85,000
Total (gains) or losses, realized and unrealized, included in earnings (1)(2)    [1]    [1]
Estimates and other changes in fair value 197 [2] 29,617 [2]
Balance, 63,838 114,617
Compensatory Stock Options Not Yet Issued [Member] | Six Months [Member]
   
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Beginning balance   378,750
Total (gains) or losses, realized and unrealized, included in earnings (1)(2)    [1] 51,823 [1]
Estimates and other changes in fair value 63,838 [2] 114,617 [2]
Settlements   (430,573)
Balance, $ 63,838 $ 114,617
[1] Unrealized gains or losses related to the accrued warrant liability were included as change in value of accrued warrant liability.
[2] Expenses recorded for compensatory stock options not yet issued are included in research & development expense and general and administrative expense.